Table 3 Association of patient factors with bleeding events
n (%)a | Any bleed (n = 43) | No bleed (n = 222) | p |
|---|---|---|---|
Female sex | 28 (65.1) | 140 (63.1) | 0.798 |
Age (mean) | 69.1 | 67.2 | 0.279 |
Renal failure | 1 (2.3) | 4 (1.8) | 0.590 |
Hepatic failure | 0 (0.0) | 3 (1.4) | 1.000 |
Diabetes | 6 (14.0) | 23 (10.4) | 0.436 |
Ischaemic Heart Disease | 0 (0.0) | 16 (7.2) | 0.083 |
Asthma and COPD | 10 (23.3) | 28 (12.6) | 0.068 |
Hypertension | 23 (53.5) | 90 (40.5) | 0.116 |
Atrial Fibrillation | 3 (7.0) | 6 (2.7) | 0.165 |
Previous VTE | 2 (4.7) | 3 (1.4) | 0.187 |
Vascular disease | 0 (0.0) | 4 (1.8) | 1.000 |
Partial joint replacement | 1 (2.3) | 7 (3.2) | 1.000 |
Hip replacement | 19 (44.2) | 132 (59.4) | 0.064 |
Primary replacement | 38 (88.3) | 214 (96.4) | 0.042 |
ACE inhibitor/ARB | 15 (34.9) | 62 (27.9) | 0.358 |
Statin | 11 (25.6) | 75 (33.8) | 0.293 |
Gastric Protection | 16 (37.2) | 75 (33.8) | 0.665 |
CCB | 10 (23.3) | 51 (23.0) | 0.968 |
Aspirin | 1 (2.3) | 11 (5.0) | 0.697 |
Clopidogrel | 1 (2.3) | 2 (0.9) | 0.413 |
Ticagrelor | 0 (0.0) | 0 (0.0) | – |
Dihydropyridine | 0 (0.0) | 0 (0.0) | – |
Diuretic | 9 (20.9) | 28 (12.6) | 0.150 |
Antiretroviral | 1 (2.3) | 2 (0.9) | 0.413 |
Warfarin | 0 (0.0) | 0 (0.0) | – |
Length of operation (mean)b | 2.16 | 2.02 | 0.188 |